[1]
Thottol, R., Sreelatha, M. and Narayanan, P. 2016. Open label study to assess the safety and efficacy of cinacalcet in refractory hyperparathyroidism with chronic renal failure. International Journal of Basic & Clinical Pharmacology. 5, 3 (Dec. 2016), 676–683. DOI:https://doi.org/10.18203/2319-2003.ijbcp20161500.